The redox-senescence axis and its therapeutic targetingNatalie Y.L. Ngoi, Shazib Pervaiz, Matthew S. Davids et al.|Redox Biology|2021Cited by 83
Serine-70 phosphorylated Bcl-2 prevents oxidative stress-induced DNA damage by modulating the mitochondrial redox metabolismStephen Jun Fei Chong, Shazib Pervaiz, Kartini Iskandar et al.|Nucleic Acids Research|2020Cited by 63
Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignanciesStephen Jun Fei Chong, Matthew S. Davids, Fen Zhu et al.|Journal of Clinical Investigation|2023Cited by 43
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemiaCharles Herbaux, Matthew S. Davids, Christoph Kornauth et al.|Blood|2021Cited by 37
Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclaxFen Zhu, Matthew S. Davids, Jennifer L. Crombie et al.|Haematologica|2023Cited by 14